All Type of News
Controversy remains over ‘pay for delay’
A tactic used in some drug patent settlement cases is creating renewed controversy concerning so-called “pay for delay” agreed between GlaxoSmithKline and Dong-A, which was made public by the Fair Trade Commission Thu...
Government’s plan to cut drug prices should be delayed
The Ministry of Health and Welfare said on August 2 that retail drug prices are expected to fall about 17 percent on average beginning next year following a set of government-led reforms.
However, Yuhan Corp. Presi...
GNP chairman opposes sale of OTC drugs at convenience stores
The Grand National Party chairman Hong Joon-pyo said Saturday that if over-the-counter (OTC) drugs are available at convenience stores that are open around the clock, it would be far more harmful to the public.
In ...
Controversy escalating over bill allowing painkillers at supermarkets
Following the reclassification of 48 over-the-counter (OTC) medicines in July, which allows them to be sold in supermarkets and convenience stores, the Ministry of Health and Welfare plans to submit a bill to allow th...
Drug makers oppose new drug pricing reform
The Korea Pharmaceutical Manufacturers Association and the government have clashed over the latter’s plan to cut drug prices by an average of 17 percent starting next year.
On Thursday, the KPMA issued a statement,...
Drugmakers’ protest may face backlash
The Korea Pharmaceutical Manufacturers Association said Thursday that it will take every possible measure to prevent the government’s plan to senseless policy to cut drug price for the survival of the pharmaceutical i...
11 pharmaceutical firms own stakes in general programming cable television channels
A total of 11 leading pharmaceutical companies, including Ildong and Hanmi, made investments on five general programming cable broadcasters - Chosun Ilbo, JoongAng Ilbo, Dong-A Ilbo, Maeil Business Newspaper and Yonha...
Abuse and dependence of OTC drugs surging
A growing number of Koreans are taking various medications, putting heavier financial pressure on the state health insurance. Younger Koreans in 10s have also become more dependent on medicines to treat minor illnesse...
No more homegrown drugs are available
The government’s plan to cut drug prices by an average of 17 percent starting next year has triggered vehement protests from the domestic pharmaceutical community.
Asserting that the government’s “senseless” plan w...
Faint hope mounting over new health minister
The domestic pharmaceutical industry has still pinned hopes on Health and Welfare Minister Rim Che-min.
Rim, 53, minister of the Prime Minister’s Office, is one of the most recognized economic bureaucrats under the...
